Jacobs Levy Equity Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
WA
Jacobs Levy Equity Management's MEDP Position: Q3 2025 in Review
Jacobs Levy Equity Management sold out of Medpace (MEDP) in Q3 2025, closing a stake of 116,249 shares — an estimated $36.5M sold.
Jacobs Levy Equity Management first reported a position in MEDP in Q1 2018 and held it in 13 quarters. The position peaked at $45.1M in Q3 2022. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.
- Jacobs Levy Equity Management reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
- Jacobs Levy Equity Management sold 116,249 Medpace shares in Q3 2025, an estimated $36.5M.
- Jacobs Levy Equity Management first reported a position in Medpace in Q1 2018 and held it in 13 quarters.
- Jacobs Levy Equity Management's Medpace position peaked at $45.1M in Q3 2022.
- 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.